Munafa Stock Market Course + Intraday & FNO calls 
Cellectis S (CLLS) Technical (Analysis) Reports Cellectis S ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Cellectis S (CLLS)
Technical Analysis Report for USA stock CLLS Cellectis S. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CLLS Cellectis S then click here. or read Experts views on Cellectis S or Forecast & share price targets of Cellectis S
Cellectis S Opened at 3.66 and Closed at: 3.57, which is 1.96% of previous session's close. It moved within a range of 3.49 and 3.66
The session was a Bearish session with an average volume of 18700, which is -366.31% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 3.45 and resistance for tomorrow is 3.62
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 3.49, 3.4 resistance for tomorrow's hourly charts is 3.66, 3.74
10 Day SMA for Cellectis S (CLLS) is 3.81 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Cellectis S (CLLS) is 4.03 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Cellectis S (CLLS) is 4.43 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 4.07 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Cellectis S is 3.03 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Cellectis S is at 4.03 and 200 DMA is at 3.03, while 50 DMA and 100 DMA are at 4.43 and 4.07 respectively
Cellectis S (CLLS) moving average of 20 SMA is at 4.03 and 20 EMA is at 3.97
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 3.57 | 4.03 | 3.97 |
| 05 Thu Feb | 3.50 | 4.07 | 4.01 |
| 04 Wed Feb | 3.54 | 4.12 | 4.06 |
| 03 Tue Feb | 3.53 | 4.17 | 4.12 |
| 02 Mon Feb | 3.82 | 4.22 | 4.18 |
| 30 Fri Jan | 3.79 | 4.27 | 4.22 |
Cellectis S (CLLS) moving average of 50 SMA is at 4.43 and 50 EMA is at 4.15
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 3.57 | 4.43 | 4.15 |
| 05 Thu Feb | 3.50 | 4.47 | 4.17 |
| 04 Wed Feb | 3.54 | 4.49 | 4.2 |
| 03 Tue Feb | 3.53 | 4.51 | 4.23 |
| 02 Mon Feb | 3.82 | 4.53 | 4.26 |
| 30 Fri Jan | 3.79 | 4.54 | 4.28 |
Cellectis S (CLLS) moving average of 100 SMA is at 4.07 and 100 EMA is at 3.88
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 3.57 | 4.07 | 3.88 |
| 05 Thu Feb | 3.50 | 4.06 | 3.89 |
| 04 Wed Feb | 3.54 | 4.06 | 3.9 |
| 03 Tue Feb | 3.53 | 4.05 | 3.91 |
| 02 Mon Feb | 3.82 | 4.05 | 3.92 |
| 30 Fri Jan | 3.79 | 4.04 | 3.92 |
Cellectis S (CLLS) moving average of 200 SMA is at 3.03 and 200 EMA is at 3.47
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 3.57 | 3.03 | 3.47 |
| 05 Thu Feb | 3.50 | 3.02 | 3.47 |
| 04 Wed Feb | 3.54 | 3.01 | 3.47 |
| 03 Tue Feb | 3.53 | 3 | 3.47 |
| 02 Mon Feb | 3.82 | 2.99 | 3.47 |
| 30 Fri Jan | 3.79 | 2.98 | 3.47 |
Conmed Corporation has performed better than Cellectis S in short term. You could have earned much better returns by investing in Conmed Corporation, about 15.81% more returns!
Cardinal Health has performed better than Cellectis S in short term. You could have earned much better returns by investing in Cardinal Health, about 31.6% more returns!
Abbvie Inc has performed better than Cellectis S in short term. You could have earned much better returns by investing in Abbvie Inc, about 20.58% more returns!
Xeris Pharmaceuticals has performed better than Cellectis S in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 7.45% more returns!
Veracyte Inc has performed better than Cellectis S in short term. You could have earned much better returns by investing in Veracyte Inc, about 5.13% more returns!
Trinity Biotech has performed better than Cellectis S in short term. You could have earned much better returns by investing in Trinity Biotech, about 28.64% more returns!
Bio Techne has performed better than Cellectis S in short term. You could have earned much better returns by investing in Bio Techne, about 20.69% more returns!
Ultragenyx Pharmaceutical has performed better than Cellectis S in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 28.78% more returns!
Seres Therapeutics has performed better than Cellectis S in short term. You could have earned much better returns by investing in Seres Therapeutics, about 8.25% more returns!
Immuron has performed better than Cellectis S in short term. You could have earned much better returns by investing in Immuron, about 14.34% more returns!
Curis Inc has performed better than Cellectis S in short term. You could have earned much better returns by investing in Curis Inc, about 43.15% more returns!
Catalyst Biosciences has performed better than Cellectis S in short term. You could have earned much better returns by investing in Catalyst Biosciences, about 7.19% more returns!
Cellectis S has performed better than Biotelemetry Inc in short term. Holding Cellectis S could be a better choice for now!
Axogen Inc has performed better than Cellectis S in short term. You could have earned much better returns by investing in Axogen Inc, about 23.29% more returns!
Anixa Biosciences has performed better than Cellectis S in short term. You could have earned much better returns by investing in Anixa Biosciences, about 6.62% more returns!
Anika Therapeutics has performed better than Cellectis S in short term. You could have earned much better returns by investing in Anika Therapeutics, about 28.92% more returns!
Akari Therapeutics has performed better than Cellectis S in short term. You could have earned much better returns by investing in Akari Therapeutics, about 1.19% more returns!
Ac Immune has performed better than Cellectis S in short term. You could have earned much better returns by investing in Ac Immune, about 11.13% more returns!
Cellectis S Technical analysis of indicators
Price action analysis of Cellectis S (CLLS) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cellectis S stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Cellectis S in short term and the sell signal is strong.
Cellectis S Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Cellectis S in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cellectis S is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.74 and Cellectis S CLLS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Cellectis S CLLS stock. Volume based technical analysis of Cellectis S CLLS stock is negative.
Cellectis S Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CLLS Cellectis S These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CLLS Experts View which covers a lot of information including buying and selling signals
CLLS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cellectis S or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Cellectis S (CLLS) Technical (Analysis) Reports Cellectis S ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
